Novo Holdings’ 2020 result is based on a strong performance from both the Investment Portfolio and the Novo Group companies (Novo Nordisk and Novozymes). “2020 was a very satisfactory year for Novo Holdings, despite the unprecedented challenges of the COVID-19 crisis. Our income and investment returns are once again well balanced, with strong contributions […]
LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, will release results on Monday, January 13, 2020 at 5.00 am GMT from a Phase 2b dose-ranging study evaluating nebulized ensifentrine as an add-on to treatment with a long acting bronchodilator […]
Key hires enhance management for next development phase 09 January 2020, Windsor, UK: Macrophage Pharma Limited (“MPL”), a biotech company focused on the discovery and development of next-generation immunomodulatory small molecules inducing transcriptional reprogramming of macrophage function to combat cancer and other diseases, announced today that it has appointed Venkat Reddy PhD as Chief Scientific Officer […]
Syndicate includes leading UK investors Amadeus Capital Partners, Delin Ventures and Kindred Capital Appoints Jason C. Foster as Chief Executive Officer January 8, 2020, London, UK and Philadelphia, USA – Ori Biotech Ltd (Ori), an innovator in Cell and Gene Therapy (CGT) manufacturing, today announced that they successfully closed a $9.4M (£7M) Seed Round which will […]
LONDON, Jan. 07, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the appointment of David Moskowitz to the newly created position of Vice President, Capital Markets Strategy & Investor Relations. Mr. Moskowitz will oversee the Company’s investor relations activities and will […]
